These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3929751)

  • 1. Teratogenic effects of valproate in the CD-1 mouse fetus.
    Paulson RB; Sucheston ME; Hayes TG; Paulson GW
    Arch Neurol; 1985 Oct; 42(10):980-3. PubMed ID: 3929751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exencephaly and axial skeletal malformations induced by maternal administration of sodium valproate in the MF1 mouse.
    Padmanabhan R; Hameed MS
    J Craniofac Genet Dev Biol; 1994; 14(3):192-205. PubMed ID: 7852547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teratogenic effects of sodium valproate in mice and rats at midgestation and at term.
    Menegola E; Broccia ML; Nau H; Prati M; Ricolfi R; Giavini E
    Teratog Carcinog Mutagen; 1996; 16(2):97-108. PubMed ID: 8875740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teratogenic effects of dosage levels and time of administration of carbamazepine, sodium valproate, and diphenylhydantoin on craniofacial development in the CD-1 mouse fetus.
    Eluma FO; Sucheston ME; Hayes TG; Paulson RB
    J Craniofac Genet Dev Biol; 1984; 4(3):191-210. PubMed ID: 6438150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teratogenic effects of sodium valproate in the Jcl: ICR mouse fetus.
    Sonoda T; Ohdo S; Ohba K; Okishima T; Hayakawa K
    Acta Paediatr Jpn; 1990 Oct; 32(5):502-7. PubMed ID: 2284927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teratogenic effects on the neuroepithelium of the CD-1 mouse embryo exposed in utero to sodium valproate.
    Turner S; Sucheston ME; De Philip RM; Paulson RB
    Teratology; 1990 Apr; 41(4):421-42. PubMed ID: 2111044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of heart malformations in B6C3F1 mouse fetuses induced by in utero exposure to methyl chloride.
    Wolkowski-Tyl R; Lawton AD; Phelps M; Hamm TE
    Teratology; 1983 Apr; 27(2):197-206. PubMed ID: 6867941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose dependence of fetal malformations associated with valproate.
    Vajda FJ; O'Brien TJ; Graham JE; Lander CM; Eadie MJ
    Neurology; 2013 Sep; 81(11):999-1003. PubMed ID: 23911758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teratogenicity of valproic acid and its constitutional isomer, amide derivative valnoctamide in mice.
    Lin YL; Bialer M; Cabrera RM; Finnell RH; Wlodarczyk BJ
    Birth Defects Res; 2019 Aug; 111(14):1013-1023. PubMed ID: 30325584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing the effects of in utero valproic acid exposure on murine fetoplacental development.
    Shafique S; Winn LM
    Placenta; 2021 Sep; 112():141-152. PubMed ID: 34352490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teratogenesis of calcium valproate in rats.
    Ong LL; Schardein JL; Petrere JA; Sakowski R; Jordan H; Humphrey RR; Fitzgerald JE; de la Iglesia FA
    Fundam Appl Toxicol; 1983; 3(2):121-6. PubMed ID: 6409702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid-induced spina bifida: a mouse model.
    Ehlers K; Stürje H; Merker HJ; Nau H
    Teratology; 1992 Feb; 45(2):145-54. PubMed ID: 1377411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embryo-lethal and teratogenic effect of the new platinum compound DPR in pregnant mice.
    Ognio E; Lapide M; Ottone M; Mandys V; Peterka M; Parodi B; Viale M
    Arch Toxicol; 2003 Oct; 77(10):584-90. PubMed ID: 14574446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of valproic acid on fetal and maternal organs in the mouse: a morphological study.
    Emmanouil-Nikoloussi EN; Foroglou NG; Kerameos-Foroglou CH; Thliveris JA
    Morphologie; 2004 Apr; 88(280):41-5. PubMed ID: 15208813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental effects of petroleum creosote on mice following oral exposure.
    Iyer PR; Irvin TR; Martin JE
    Res Commun Chem Pathol Pharmacol; 1993 Dec; 82(3):371-4. PubMed ID: 8122038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of supplementation with folinic acid, vitamin B6, and vitamin B12 on valproic acid-induced teratogenesis in mice.
    Elmazar MM; Thiel R; Nau H
    Fundam Appl Toxicol; 1992 Apr; 18(3):389-94. PubMed ID: 1597263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy.
    Vajda FJ; O'brien TJ; Hitchcock A; Graham J; Cook M; Lander C; Eadie MJ
    J Clin Neurosci; 2004 Nov; 11(8):854-8. PubMed ID: 15519862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
    Ornoy A
    Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphological changes induced by valproate and its administration concomitant with folinic acid or S-adenosylmethionine in pregnant rats].
    Ubeda-Martín N; Alonso-Aperte E; Achón M; Varela-Moreiras G; Puerta J; Pérez de Miguelsanz J
    Nutr Hosp; 1998; 13(1):41-9. PubMed ID: 9578686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic acid-induced fetal malformations are reduced by maternal immune stimulation with granulocyte-macrophage colony-stimulating factor or interferon-gamma.
    Hrubec TC; Yan M; Ye K; Salafia CM; Holladay SD
    Anat Rec A Discov Mol Cell Evol Biol; 2006 Dec; 288(12):1303-9. PubMed ID: 17075842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.